Leukocare AG

Biotechnology ResearchBavaria, Germany51-200 Employees

Leukocare AG is a biotechnology research company headquartered in Planegg, Bavaria, Germany (19a am Klopferspitz), with 51-200 employees. For more than 20 years, it provides formulation development services guided by a Quality by Design framework to pharmaceutical companies, mid-sized biotech firms, and innovative biotechs, supporting programs from pre-formulation through clinical advancement and IP protection. The company combines formulation expertise with data science and statistical methods to pursue an evidence-based development path and has extensive experience in liquid and lyophilized formulations for proteins, monoclonal antibodies, viral vectors, and viruses, utilizing a catalog of 100+ regulatory-approved excipients. Typical projects include molecular modeling and benchmarking, pre-formulation, QbD formulation development and optimization, process development and transfer, and IP support, all within a framework that emphasizes regulatory requirements and adaptability to evolving drug-development landscapes. The firm has engaged in partnerships and funding activity, including a 2021 financing round of $17.5 million led by Petrichor and collaborations such as ReiThera for vaccine formulation; Leukocare also has operations in Milford, Connecticut as part of its international presence. The company’s website is leukocare.com.

Sign up for free to view info

Email Format Employee directory